glp-1 drugs for type 1 diabetes Comparing Ozempic, Wegovy and Other GLP-1 Medications for Weight Loss:

Theoretically the loss of lean mass could be prevented, but it is extremely difficult in practice, and therefore impossible (or highly unlikely) for most people

Stopping medication without a maintenance plan frequently leads to weight regain because the biological drivers of obesity return

Because it works partly like GLP-1 medicines, researchers want to know if it may help with metabolic and heart-related conditions

More recently, sodium-glucose cotransporter type 2 inhibitors have demonstrated to offer cardiovascular and renal protection, but the residual risk remains high and their antihyperglycemic efficacy is limited in moderate-severe CKD

Retatrutide is the most advanced triple agonist in clinical research, but other compounds are in earlier-stage development